These precedents suggest that the upregulation of IL-8 and KLF5 observed in ZO-1-deficient ovarian cancer cells may reflect a broader function of ZO-1 in modulating transcriptional activity, linking tight junction integrity to gene expression pathways that drive angiogenesis. Here, KLF5 is linked to ovarian cancer.